Literature DB >> 11844990

New insights into erythropoiesis.

Mark J Koury1, Stephen T Sawyer, Stephen J Brandt.   

Abstract

Commitment of hematopoietic cells to the erythroid lineage involves the actions of several transcription factors, including TAL1, LMO2, and GATA-2. The differentiation of committed erythroid progenitor cells involves other transcription factors, including NF-E2 and EKLF. Upon binding erythropoietin, the principal regulator of erythropoiesis, cell surface erythropoietin receptors dimerize and activate specific intracellular kinases, including Janus family tyrosine protein kinase 2, phosphoinositol-3 kinase, and mitogen-activated protein kinase. Important substrates of these kinases are tyrosines in the erythropoietin receptors themselves and the signal transducer and transcription activator proteins. Erythropoietin prevents erythroid cell apoptosis. Some of the apoptotic tendency of erythroid cells can be attributed to proapoptotic molecules produced by hematopoietic cells, macrophages, and stromal cells. Cell divisions accompanying terminal erythroid differentiation are finely controlled by cell cycle regulators, and disruption of these terminal divisions causes erythroid cell apoptosis. In reticulocyte maturation, regulated degradation of internal organelles involves a lipoxygenase, whereas survival requires the antiapoptotic protein Bcl-x.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844990     DOI: 10.1097/00062752-200203000-00002

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  60 in total

1.  Population pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human Epoetin Alfa and the Biosimilar HX575.

Authors:  Xiaoyu Yan; Philip J Lowe; Martin Fink; Alexander Berghout; Sigrid Balser; Wojciech Krzyzanski
Journal:  J Clin Pharmacol       Date:  2011-12-12       Impact factor: 3.126

2.  A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells.

Authors:  Michael R Tallack; Tom Whitington; Wai Shan Yuen; Elanor N Wainwright; Janelle R Keys; Brooke B Gardiner; Ehsan Nourbakhsh; Nicole Cloonan; Sean M Grimmond; Timothy L Bailey; Andrew C Perkins
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

3.  Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.

Authors:  Zhihong Wan; Ning Zhi; Susan Wong; Keyvan Keyvanfar; Delong Liu; Nalini Raghavachari; Peter J Munson; Su Su; Daniela Malide; Sachiko Kajigaya; Neal S Young
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

4.  Maturation and enucleation of primitive erythroblasts during mouse embryogenesis is accompanied by changes in cell-surface antigen expression.

Authors:  Stuart T Fraser; Joan Isern; Margaret H Baron
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

5.  EKLF and KLF2 have compensatory roles in embryonic beta-globin gene expression and primitive erythropoiesis.

Authors:  Priyadarshi Basu; Tina K Lung; Wafaa Lemsaddek; Thanh Giang Sargent; David C Williams; Mohua Basu; Latasha C Redmond; Jerry B Lingrel; Jack L Haar; Joyce A Lloyd
Journal:  Blood       Date:  2007-08-03       Impact factor: 22.113

6.  Erythropoietin and blood doping.

Authors:  N Robinson; S Giraud; C Saudan; N Baume; L Avois; P Mangin; M Saugy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

7.  Differential gene expression during terminal erythroid differentiation.

Authors:  S Koury; S Yarlagadda; K Moskalik-Liermo; N Popli; N Kim; C Apolito; A Peterson; X Zhang; P Zu; J Tamburlin; D Bofinger
Journal:  Genomics       Date:  2007-08-31       Impact factor: 5.736

Review 8.  Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin level.

Authors:  Jaime Sanz Ortiz
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

9.  Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2.

Authors:  Andre M Pilon; Murat O Arcasoy; Holly K Dressman; Serena E Vayda; Yelena D Maksimova; Jose I Sangerman; Patrick G Gallagher; David M Bodine
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

10.  JNK-mediated turnover and stabilization of the transcription factor p45/NF-E2 during differentiation of murine erythroleukemia cells.

Authors:  Tung-Liang Lee; Yu-Chiau Shyu; Pang-Hung Hsu; Chiung-Wen Chang; Shau-Ching Wen; Wei-Yuan Hsiao; Ming-Daw Tsai; Che-Kun James Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.